Lin L. Liu

发表

DNA replication timing and higher-order nuclear organization determine single nucleotide substitution patterns in cancer genomes

S. De, F. Michor, Lin L. Liu, 2013, Nature Communications.

Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients

Fei Li, William Pao, Franziska Michor, 2015, PloS one.

The mathematics of cancer: integrating quantitative models

Philipp M. Altrock, Franziska Michor, F. Michor, 2015, Nature Reviews Cancer.

Nuclear topology modulates the mutational landscapes of cancer genomes

Subhajyoti De, Shridar Ganesan, Franziska Michor, 2017, Nature Structural & Molecular Biology.

Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.

T. Sørlie, F. Beca, G. Freeman, 2017, Cancer discovery.

In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2+ breast cancer

Franziska Michor, Jorge S. Reis-Filho, Carlos L. Arteaga, 2015, Nature Genetics.

Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell lines identifies spectrum of DNA changes associated with drug resistance

Junfeng Xia, Peilin Jia, William Pao, 2013, Genome research.

resistance lines identifies spectrum of DNA changes associated with drug inhibitor-sensitive and-resistant EGFR mutant lung cancer cell Next-generation sequencing of paired tyrosine kinase Material Supplemental

Zhongming Zhao, P. Jia, W. Pao, 2013 .

Probabilistic Modeling of Reprogramming to Induced Pluripotent Stem Cells.

Zachary D. Smith, J. Brumbaugh, K. Hochedlinger, 2016, Cell reports.

mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors.

Franziska Michor, Karen Cichowski, F. Michor, 2017, Cancer discovery.

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer

Yoh Iwasa, Franziska Michor, Kevin Leder, 2015, PLoS Comput. Biol..

Dark selection for JAK/STAT-inhibitor resistance in chronic myelomonocytic leukemia

D. Basanta, A. Marusyk, A. Dhawan, 2017, bioRxiv.

Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies

Franziska Michor, Mithat Gonen, Kazuhisa Uchiyama, 2019, PloS one.

Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion.

F. Michor, Lin L. Liu, H. Haeno, 2019, JCO clinical cancer informatics.

The mathematics of cancer: integrating quantitative models

F. Michor, P. Altrock, Lin L. Liu, 2015, Nature Reviews Cancer.

Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies

M. Gonen, F. Michor, C. Kong, 2019, PloS one.